![EP 60: The Year 2021 in Review with Dr Sukh Nijjer – Part 1| recent cardiology trials](https://assets.radcliffecardiology.com/s3fs-public/podcast/2024-03/EP_60.png?VersionId=x8pIMdjzIO6UUET8mGUAqfsZqj.8weon)
In the last Parallax episode of the year,Dr Ankur Kalra welcomed back Dr Sukh Nijjer, Interventional Cardiologist from Imperial College London, to review the most impactful events and advances in cardiology from 2021.
This year we had a number of studies that helped clarify our understanding of the world of antiplatelets: First, Ankur and Sukh discuss the take-home messages from HOST-EXAM, a Korean study presented at ACC 2021. They discuss their clinical experiences within the UK and US setting. Next, Sukh talks about the STOPDAPT-2 ACS study, presented at ESC 2021. Sukh interprets the findings in the light of TWILIGHTand summarises his thoughts on the therapy.
2021 was not a great year for physiology: Sukh shares his take on FLOWER-MI, presented at ACC 2021. He offers a deep dive into the data and highlights both the importance of the findings and the limitations of the study.
Next, they discuss RIPCORD 2 from ESC 2021 and finally, Sukh highlights the findings from the FAME 3 trial.
What is the importance of genotype testing in the world of antiplatelets? What are the considerations for clinicians? Should we stop using FFR? How can we incorporate novel findings to patient care? What are the practical considerations that we should take into account when looking at the physiology trials of 2021?
Stay tuned for Part 2 - heart failure and surgical trials coming in 2022.
Questions and comments can be sent to “podcast@radciffe-group.com” and may be answered by Ankur in the next episode. Guest @SukhNijjer, hosted by @AnkurKalraMD. Produced by @RadcliffeCARDIO.
![Edwards: www.edwardstavr.com](https://assets.radcliffecardiology.com/article/2024-03/edwards_logo_v2_423_rgb_pos_jpg_3.jpg?VersionId=wvCe3eONeAb99zHg.28xvhD2n6mr2qy_)
Brought to you by Edwards: www.edwardstavr.com
![EP 61: The Year 2021 in Review with Dr Sukh Nijjer — Top Trials in Heart Failure and Cardiac Surgery](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/1920x1080_PP_EP61.png?VersionId=GBUOTD1Now0KlMBv1ZqsaenpUrh7dUtk&itok=ZyO2ze7u)
![EP 64: Patient Advocate, CHD Care and the Mission of Team Uncle Joe with Joe Valente](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/1920x1080_Web_Artwork_Parallax_2022_0.png?VersionId=gBfQlPbRV1Jo1VR76XaBdCXvr4fNGvjp&itok=I9nEiYzP)
![EP 63: Innovation, Research, and the Concept of Hemorrhagic MI with Dr Rohan Dharmakumar](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/1920x1080_Web_Artwork_Parallax_2022.png?VersionId=DSOXwApj0IrcM1xYKfUv0f8.e6LEe_kh&itok=uJgbahtI)
![EP 62: Bullying, Harassment and Jealousy at Workplace with Dr Srihari S Naidu](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/1920x1080_EP62_PP.png?VersionId=iXp8vDsebm7W_M3eLJUYkC9b.ad5_mkb&itok=kLDg7s8y)
![EP 61: The Year 2021 in Review with Dr Sukh Nijjer — Top Trials in Heart Failure and Cardiac Surgery](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/1920x1080_PP_EP61.png?VersionId=GBUOTD1Now0KlMBv1ZqsaenpUrh7dUtk&itok=ZyO2ze7u)
![EP 60: The Year 2021 in Review with Dr Sukh Nijjer – Part 1| recent cardiology trials](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/1920x1080_PP_EP60.png?VersionId=5RD29a41Ka6RNtdDgzazifTh_tnmcFut&itok=vkisLegl)
![Parallax AHA Edition: 3 Trials that will change your practice with Dr Amit Khera](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/EP59_PP_1920x1080_Web_Thumbnail.png?VersionId=R.EhdsJ426kSouiUM7QobjhJoBxYBRuk&itok=x73s1klk)
![Parallax TCT Edition: 3 Trials that will Change Your Practice with Prof Mamas Mamas](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/PP_EP58_1920x1080_Web_Thumbnail.png?VersionId=wvsTjPMZ2PhW5QUtl9QIEj6FIS3xwS4A&itok=TzPo3hwm)
![Academic Success, Decision-making & Pragmatic Approach](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/EP57_PP_Social_Artwork2_0.png?VersionId=Z.tlaafPFucKKSQY1g6gOM5MfOLlPqI8&itok=kzt1-DFg)
![Parallax HFSA Edition: Diversity, Equity, Inclusion & Belonging with Dr Nancy M. Albert](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/EP56_PP_Social_Artwork2.png?VersionId=VZ0MM2neqFfUYaGSKTxejSWQQtSYxynC&itok=JfvloKdX)
![EP 55: 5 Interventional trials that will change your practice: Review of ESC 21 with Dr Mirvat Alasnag](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/EP55_PP_Social_Artwork2.png?VersionId=XqydymW5RgIx79bXep7IXBqs_.sPbpd.&itok=W6tcWoX7)
![EP 39: The Year 2020 in Review with Sukh Nijjer](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/Parallax_39_1200.jpeg?VersionId=JU1Gu8abffSo_fwsmEhL5s9f7I0rM30L&itok=boZinKUo)
Which COVID19 patients require risk stratification with a stress test? What are the take-home messages for physicians taking care of patients diagnosed with COVID19? What were the key trials of 2020? What can we learn from the negative results of the STRENGHT study? How have studies like STOP-AF influenced clinical practice?
![38: Martin B Leon on CRF, Mentorship and the Lessons of 2020](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/Parallax_38-2.jpeg?VersionId=T6upLePKIpYZ8wBmEH9dkg65vQvHOFiZ&itok=990rBdAf)
What makes Dr Martin B Leon tick? What is his message to cardiologists and/or researchers at the beginning of their careers? How did the pandemic and his work as a clinician in New York change his perspective?
![37: Lindsay’s Law: From Ballerina to Health Advocate](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/Parallax_37.jpeg?VersionId=O1.0MQFT2P0xtVa5F3cpEE6jfvnmYcWO&itok=NmREiPwF)
In this episode Ankur asks Lindsay about her treatment path. Lindsay recalls her own journey to taking control of her condition and the important role of information in patient adherence. Lindsay, former Miss Ohio, talks how she used the pageant to create awareness. Lindsay talks about work in state legislation and her plans for 2021.
![WiC, Mentorship and Diversity in Academic Publishing](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/Parallax_362.jpeg?VersionId=g6awb.OYio50oxPdztK5P0q39ElFjL.3&itok=RzaRIq05)
US Cardiology Review journal, has recently seen a 7-fold increase in female editorial board members in response to journal-based strategic initiatives and the stellar work of USC editorial board leadership, Ankur Kalra (Editor in Chief) and Bill Gogas (Deputy Editor in Chief), who were keen to drive this change. With thanks to Dr Anastasia Mihailidou’s tenure as a new board member and her suggested nominees, ten new female board members have recently joined US Cardiology Review’s editorial board.
![C Mike Gibson On Art, Medicine And Fatherhood](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/Parallax_35.jpeg?VersionId=_scA1cR65PQLHsP1aHMOB2Od3r_XlXkQ&itok=Ngbr59ew)
In this episode, Mike opens up about his childhood in Stilwell, Oklahoma. Ankur and Mike discuss how the inductive quality of art can complement the deductive principles of science. Mike recalls earlier stages of his career and warns about the blinding effect of the ego-driven, competitive culture of cardiology. Ankur asks Mike about fatherhood and about his role as an educator.
What does it mean to be fearless as a medical professional? How can you protect yourself from the emotional toll of the profession? What is Mike’s advice to early career cardiologists?
Sponsored by Edwards.